In this free webinar, learn how integrated ADME tools and AI-driven human pharmacokinetic projection can help bring human PK ...

BioFocus DPI has announced that it has strengthened its ADME/PK Laboratory bioanalytical capabilities through the installation of a Waters® Xevo™ TQ Mass Spectrometer. As one of the first ...

BioFocus DPI, a leading provider of gene-to-preclinical discovery services, announces the launch of ADME/PK Laboratory and the StarDrop TM software platform. ADME/PK Laboratory is the new name for the ...

Historically, it was not possible to detect ADME problems until the IND application preparation stage, which often led to “serious disruption of the development process, and often resulted in closure ...

The company's expansion in the biological assay space aided by the data platform SAN FRANCISCO and KYIV, Ukraine, June 10, 2021 /PRNewswire/ -- Enamine, a leading provider of R&D Services as well as ...

SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more ...

Fail fast, fail cheap is a common clich in drug development. Studies project that anywhere from 4060% of potential drugs candidates fail in development due to absorption, distribution, metabolism, ...

Historically, the majority of compounds that failed in development did so because of poor pharmacokinetic (PK) properties. More recently, PK and ADME testing is being done earlier and in parallel with ...

Experts discuss factors that can affect the outcome of an ADME study, signs that a drug compound shows promise, red flags, and key parameters to determine safety and efficacy. Absorption, distribution ...